# LAV Asset Management

LAV Asset Management is an Asset Manager based in Hong Kong, Hong Kong.

## Overview

- **Organization type:** Asset Manager
- **Headquarters:** Hong Kong, Hong Kong
- **Region:** Asia
- **Address:** Hong Kong, Hong Kong
- **Founded:** 2007
- **Assets under management:** Undisclosed
- **Website:** lavfund.com

## Regulatory record

- **CRD number:** 326019
- **SEC file number:** 802-128589
- **Registration status:** Registered
- **Reports private funds:** Yes
- **IAPD record:** https://adviserinfo.sec.gov/firm/summary/326019

## About

LAV ASSET MANAGEMENT (HONG KONG) LIMITED is an exempt reporting adviser in Hong Kong. It is based in Hong Kong.

## Sectors

- Healthcare Services
- Digital Health
- Biotech

## Offices

- Shanghai, China

## People

- Yi Shi — Founder and Managing Partner
- James Zhi — Managing Partner

## Questions

### Who runs investment decisions at LAV?

Founder Yi Shi and Managing Partner James Zhi anchor the investment committee. Shi holds a PhD in biochemistry and brings a scientific lens to portfolio construction. The firm keeps its senior partner group small, with investment decisions made by the partnership rather than a single CIO.

### What investment stages does LAV typically target?

LAV invests from early-stage venture through crossover and growth equity. The firm can hold positions from company formation through IPO and follow-on rounds. Its portfolio companies often list on Nasdaq or the Hong Kong Exchange, with LAV sometimes maintaining a position post-listing to capture commercial-stage growth.

### Which sectors does LAV explicitly avoid?

LAV is exclusively life sciences and healthcare. The firm does not invest in consumer internet, enterprise software, fintech, or any non-healthcare verticals. Within healthcare, its portfolio spans biopharmaceuticals, medical devices, and diagnostics, but it does not pursue healthcare services or provider models outside of the innovation supply chain.

### How does LAV source proprietary deal flow?

Academic spinouts and translational science labs form a critical sourcing channel, given the founding team's scientific credentials. LAV also relies on relationships with major pharmaceutical strategics who flag collaboration-ready assets. Its narrow mandate and hands-on board participation give the firm visibility into companies before they run broad auction processes.

### Does LAV participate in fund commitments or only direct deals?

LAV deploys capital exclusively through direct equity investments in portfolio companies. The firm does not operate a fund-of-funds program, nor does it allocate to external managers as a core strategy. Its fund vehicles are direct-investment venture and growth equity pools.

### What is LAV's known posture on co-investments alongside external GPs?

LAV syndicates with other life sciences specialists and generalist crossover funds on larger growth rounds. The firm does not publicly market a co-investment program, but its participation in consortium deals alongside global healthcare investors is a regular feature of later-stage rounds for its portfolio companies preparing for public listing.

## Related profiles

- [Income Associates](https://altss.com/profile/income-associates)
- [Calvert Impact Advisory Services](https://altss.com/profile/calvert-impact-advisory-services-llc)

---

Last updated: 2026-08-14T12:30:00.000Z

Canonical page: https://altss.com/profile/lav-asset-management-hong-kong-limited

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology